Literature DB >> 19578713

The pre-capillary segment of the blood-brain barrier and its relation to perivascular drainage in Alzheimer's disease and small vessel disease.

Dietmar R Thal1.   

Abstract

The blood-brain barrier (BBB) is the border between the brain tissue and the blood and consists of a pre- and post-capillary and a capillary segment. At capillaries protein transport is possible via receptor-mediated endocytosis through endothelial cells. At the arteries and veins the BBB is thicker and there is, under physiological conditions, no direct transport from the brain tissue to the blood or vice versa. Here, extracellular fluid is drained into the perivascular space, which is a fluid-filled space between the border of the brain tissue, the glia limitans, and that of the vessel wall, the adventitia as well as along basement membranes within the vessel wall. In the event of degenerative changes in the arterial vessel wall, known as small vessel disease (SVD), leakage of plasma proteins into the vessel wall and into the perivascular space occurs. Thus, the pre-capillary segment of the BBB is altered and drainage of extracellular fluid from the brain tissue competes with the leaking plasma for perivascular drainage. Since the amyloid beta-protein (Abeta) is subject of this perivascular drainage and accumulates in the brains of Alzheimer's disease (AD) patients, an alteration of this drainage system in the course of SVD may support the accumulation of Abeta within the brain and, in so doing, the development of AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578713      PMCID: PMC5823174          DOI: 10.1100/tsw.2009.72

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  13 in total

Review 1.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

Review 2.  Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.

Authors:  Michelle A Erickson; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

Review 3.  Role of ABC transporters in the pathogenesis of Alzheimer's disease.

Authors:  Alaa H Abuznait; Amal Kaddoumi
Journal:  ACS Chem Neurosci       Date:  2012-10-11       Impact factor: 4.418

Review 4.  Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain.

Authors:  Dietmar Rudolf Thal; Lea Tenenholz Grinberg; Johannes Attems
Journal:  Exp Gerontol       Date:  2012-06-13       Impact factor: 4.032

Review 5.  A showcase of bench-to-bedside regenerative medicine at the 2010 ASNTR.

Authors:  David J Eve; Cesar V Borlongan; Paul R Sanberg
Journal:  ScientificWorldJournal       Date:  2011-10-23

6.  Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.

Authors:  Oliver Goldhardt; Inanna Warnhoff; Igor Yakushev; Ilijana Begcevic; Hans Förstl; Viktor Magdolen; Antoninus Soosaipillai; Eleftherios Diamandis; Panagiotis Alexopoulos; Timo Grimmer
Journal:  Transl Neurodegener       Date:  2019-08-27       Impact factor: 8.014

7.  LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivo.

Authors:  Timo Grimmer; Oliver Goldhardt; Liang-Hao Guo; Behrooz H Yousefi; Stefan Förster; Alexander Drzezga; Christian Sorg; Panagiotis Alexopoulos; Hans Förstl; Alexander Kurz; Robert Perneczky
Journal:  Neuroimage Clin       Date:  2014-02-05       Impact factor: 4.881

Review 8.  A new look at cerebrospinal fluid circulation.

Authors:  Thomas Brinker; Edward Stopa; John Morrison; Petra Klinge
Journal:  Fluids Barriers CNS       Date:  2014-05-01

9.  Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer's disease.

Authors:  Konstantin Kotliar; Christine Hauser; Marion Ortner; Claudia Muggenthaler; Janine Diehl-Schmid; Susanne Angermann; Alexander Hapfelmeier; Christoph Schmaderer; Timo Grimmer
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

10.  Decreased Vascular Pulsatility in Alzheimer's Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography.

Authors:  Holger Poppert; Timo Grimmer; Marion Ortner; Christine Hauser; Christoph Schmaderer; Claudia Muggenthaler; Alexander Hapfelmeier; Christian Sorg; Janine Diehl-Schmid; Alexander Kurz; Hans Förstl; Benno Ikenberg; Konstantin Kotliar
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.